首页> 外文期刊>Teratogenesis, carcinogenesis, and mutagenesis >Effects of griseofulvin in medium-term liver carcinogenesis assay and peripheral blood micronucleus test in rat.
【24h】

Effects of griseofulvin in medium-term liver carcinogenesis assay and peripheral blood micronucleus test in rat.

机译:灰黄霉素在大鼠中期肝癌变分析和外周血微核试验中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Published data have suggested a possible link between the tumor promoting activity and the aneugenic properties of griseofulvin. The present study was conducted to explore this relationship. Griseofulvin was evaluated both for its potential promoting activity in liver carcinogenesis in partially hepatectomized F344 male rats initiated by diethylnitrosamine and for its genotoxic potential in the peripheral blood micronucleus assay. Rats were treated daily with 2,000 mg/kg body weight by oral gavage for 12 weeks in the medium-term carcinogenesis bioassay. GST-P-positive foci (mean number and surface area) and altered cell foci were compared in the liver of rats treated with griseofulvin alone, diethylnitrosamine alone,and griseofulvin in addition to diethylnitrosamine by using immunohistochemical and histopathological evaluation, respectively. This evaluation allowed the conclusion that griseofulvin did not initiate the carcinogenic process but rather had a potential in the liver for tumor promoting activity. Griseofulvin was found to be negative in the rat peripheral blood micronucleus test when given at a daily oral dose of 2,000 mg/kg body weight for at least 3 weeks. Copyright 2001 Wiley-Liss, Inc.
机译:已发表的数据表明肿瘤促进活性和灰黄霉素的气变特性之间可能存在联系。进行本研究以探索这种关系。对灰黄霉素在由二乙基亚硝胺引发的部分肝切除的F344雄性大鼠中在肝癌发生中的潜在促进活性以及在外周血微核试验中的遗传毒性潜力进行了评估。在中期致癌生物测定法中,每天通过口服管饲法以2,000 mg / kg体重对大鼠治疗12周。分别通过免疫组织化学和组织病理学评估,比较了单独用灰黄霉素,单独的二乙基亚硝胺和灰黄霉素治疗的大鼠肝脏中GST-P阳性灶(平均数和表面积),并比较了其改变的细胞灶。该评估得出的结论是灰黄霉素不启动致癌过程,而是在肝脏中具有促进肿瘤活性的潜力。当每天口服剂量为2,000 mg / kg体重至少3周时,在大鼠外周血微核试验中发现灰黄霉素为阴性。版权所有2001 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号